| #26 |
Uta Glufke |
Lonza |
1 |
| #26 |
Daniel Hunziker |
Basilea Pharmaceutica Ag |
1 |
| #26 |
Hanno R. Van der Wal |
Dow Global Technologies |
1 |
| #26 |
Jörn Stitz |
4-Antibody Ag |
1 |
| #26 |
Bernhard Wietfeld |
Novartis Ag |
1 |
| #26 |
Vito Guagnano |
Novartis Ag |
1 |
| #26 |
Campbell Page |
Ciba-Geigy |
1 |
| #26 |
Walter Niklaus Polt |
Habasit Ag |
1 |
| #26 |
Roger Seiler |
Sartorius Ag |
1 |
| #26 |
Silvia Schintke |
University Of Basel |
1 |
| #26 |
Paolo Fancelli |
Stoll Giroflex Ag |
1 |
| #26 |
Daniel Künzi |
Huntsman Advanced Materials Americas |
1 |
| #26 |
Pietro Regazzoni |
Synthes Ag Chur |
1 |
| #26 |
Stefano Biondi |
Nicox S.A. |
1 |
| #26 |
Simon Berner |
Straumann Holding Ag |
1 |
| #26 |
Denise Blum |
Hoffmann-La Roche |
1 |
| #26 |
Andreas Maunz |
Hoffmann-La Roche |
1 |
| #26 |
Jacques Chollet |
Medicines For Malaria Venture |
1 |
| #26 |
Gerald Wayne Craig |
Sandoz Ag |
1 |
| #26 |
Jochen Nicolai |
Cochlear Limited |
1 |
| #26 |
Michael De Wild |
Straumann Holding Ag |
1 |
| #26 |
Hugues Matile |
Medicines For Malaria Venture |
1 |
| #26 |
Jens Pohlmann |
Bayer Healthcare |
1 |
| #26 |
Erwin Marti |
Novartis Ag |
1 |
| #26 |
Yves-Alain Barde |
Regeneron Pharmaceuticals |
1 |
| #26 |
Max Angst |
Syngenta Crop Protection Ag |
1 |
| #26 |
Alexander Baxter Smith |
Novartis Ag |
1 |
| #26 |
Josef Ehrenfreund |
Ciba-Geigy |
1 |
| #26 |
Thierry Schlama |
Novartis Ag |
1 |
| #26 |
Rosa Maria Rodriguez-Sarmiento |
— |
1 |
| #26 |
Anna Vulpetti |
Novartis Ag |
1 |
| #26 |
Bertrand Sutter |
Novartis Ag |
1 |
| #26 |
Stefan Stutz |
Novartis Ag |
1 |
| #26 |
Manfred Kohlmeyer |
Novartis Ag |
1 |
| #26 |
Hans Jürg Kirner |
Basf Se |
1 |